This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMDHQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,683.61 firm fixed-price delivery order is for the specialty drug Repatha (140 mg/mL) and has an ultimate completion date of December 4, 2024.
The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract award did not have a set-aside designation, indicating open competition.
Generated 3/4/25, 11:23 AM